New treatment effective for 88% of liver cancer patients

And a new treatment pioneered in the UK has delivered impressive results for patients.

New method works in 88% of patients Shutterstock

While 49% of cases Liver Cancer If it is preventable, only about 13 per cent of patients survive five or more years after the onset of the disease, says Cancer Research UK.

However, recently, a new treatment method developed by the University of Southampton (UK) development could be a breakthrough, according to the British daily Express.

The new treatment uses 2 tiny balloons to redirect blood around the liver for 1 hour while delivering medication directly into the liver.

This is called chemosaturation therapy. This procedure allows doctors to use a much higher dose of the drug than usual.

Moreover, this method also isolates the liver and protects healthy parts of the body from being affected by chemotherapy.

After the drug is administered to the patient, blood is drawn from the liver and processed to reduce toxicity.

When this process is complete, the blood will be returned.

Once the drug has been infused, blood from the liver is withdrawn from the patient and processed through a filter to reduce toxicity ILLUSTRATION: Shutterstock

The results, published in the medical journal Melanoma Researchfound this method to be effective in 88% of patients, according to Express.

Based on the success of this approach, the researchers hypothesized that cycles of chemotherapy satiating the cancer completely in some cases.

Dr Stedman, co-founder of cancer charity Planets, said: “This method allows the liver to be shut off from the body for 60 minutes, soaked in high doses of drugs, and then filtered almost completely clean. completely before reinserting.

Study co-author Professor Neil Pearce said these results now open the door to future studies with other difficult-to-treat cancers that affect the liver, and they are exploring ways potential new research test.

There have also been a handful of studies on other types of cancer – including bowel, breast, pancreas and neuroendocrine, Professor Pearce said.

These findings suggest there is real potential for this treatment to extend to more common cancers, which is exciting, Pearce hopes, according to the study. Express.